Published in Dialogues Clin Neurosci on January 01, 2007
Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress (2009) 1.61
Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest (2008) 1.57
Dietary fat intake and the risk of depression: the SUN Project. PLoS One (2011) 1.20
Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure. J Psychosom Res (2010) 1.12
Stressful life events, chronic difficulties, and the symptoms of clinical depression. J Nerv Ment Dis (2009) 1.12
Organization of brain somatomotor-sympathetic circuits. Exp Brain Res (2008) 1.07
Long-term body weight outcomes of antidepressant-environment interactions. Mol Psychiatry (2010) 0.96
Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models. Neurosci Biobehav Rev (2008) 0.93
Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression. Psychol Bull (2014) 0.90
Frailty and depression in older adults: a high-risk clinical population. Am J Geriatr Psychiatry (2013) 0.90
Social inequalities in mental health and mortality among refugees and other immigrants to Sweden--epidemiological studies of register data. Glob Health Action (2013) 0.88
The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health. Soc Personal Psychol Compass (2011) 0.81
The integration of depressive behaviors and cardiac dysfunction during an operational measure of depression: investigating the role of negative social experiences in an animal model. Psychosom Med (2012) 0.81
Altered Connexin 43 and Connexin 45 protein expression in the heart as a function of social and environmental stress in the prairie vole. Stress (2014) 0.79
Developmental origins of cardiovascular disease: Impact of early life stress in humans and rodents. Neurosci Biobehav Rev (2016) 0.77
Depression and cardiovascular disease: just an urban legend? Psychiatry (Edgmont) (2008) 0.76
Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma. Rev Bras Psiquiatr (2010) 0.76
Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS). PLoS One (2015) 0.76
P2X(7) Receptors as a Transducer in the Co-Occurrence of Neurological/Psychiatric and Cardiovascular Disorders: A Hypothesis. Cardiovasc Psychiatry Neurol (2009) 0.76
Sex-Specific Effects of Stress on Metabolic and Cardiovascular Disease: Are women at a higher risk? Am J Physiol Regul Integr Comp Physiol (2017) 0.76
Prevalence of depressive symptoms and its correlations with positive psychological variables among Chinese medical students: an exploratory cross-sectional study. BMC Psychiatry (2016) 0.75
Physical versus psychological social stress in male rats reveals distinct cardiovascular, inflammatory and behavioral consequences. PLoS One (2017) 0.75
Opinion: "Heart Rate Variability, Health and Well-Being: A Systems Perspective" Research Topic. Front Public Health (2017) 0.75
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 45.33
Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Smoking, smoking cessation, and major depression. JAMA (1990) 5.89
Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation (2004) 4.49
Prevalence of smoking among psychiatric outpatients. Am J Psychiatry (1986) 4.32
The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry (2005) 3.96
Depression, heart rate variability, and acute myocardial infarction. Circulation (2001) 3.57
Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation (2002) 3.47
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41
Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res (2002) 3.27
Depression and the course of coronary artery disease. Am J Psychiatry (1998) 3.17
Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol (2001) 3.16
Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med (2003) 3.16
The impact of adverse childhood experiences on health problems: evidence from four birth cohorts dating back to 1900. Prev Med (2003) 3.02
Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med (2000) 2.86
Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2004) 2.84
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol (2002) 2.67
Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med (2000) 2.62
Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet (2001) 2.49
Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med (2005) 2.36
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28
Selective serotonin reuptake inhibitors and myocardial infarction. Circulation (2001) 2.14
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med (2006) 2.13
Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA (1988) 2.12
Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation (2003) 2.07
Affective disorders and mortality. A general population study. Arch Gen Psychiatry (1987) 1.95
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab (2005) 1.77
Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry (2004) 1.68
Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry (2003) 1.68
Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med (1989) 1.65
A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med (2003) 1.53
Childhood maltreatment as a risk factor for adult cardiovascular disease and depression. J Clin Psychiatry (2004) 1.52
Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol (2005) 1.48
Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res (2000) 1.47
Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry (2004) 1.46
General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart (2005) 1.41
Prospective study of depressive symptoms and risk of stroke among japanese. Stroke (2001) 1.36
Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry (1997) 1.34
The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost (2004) 1.27
Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf (2004) 1.25
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24
A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics (2003) 1.13
Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med (2004) 1.10
Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry (2006) 1.09
Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry (2006) 1.05
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail (2003) 1.05
Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol (2006) 0.99
Increased platelet aggregability in major depression? Psychiatry Res (2001) 0.94
Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry (2001) 0.93
Preventing depression after stroke: Results from a randomized placebo-controlled trial. J Clin Psychiatry (2006) 0.92
Depressive symptoms are associated with increased systemic vascular resistance to stress. Psychosom Med (2005) 0.92
Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment. Depress Anxiety (2002) 0.87
Depressive symptoms and development of coronary heart disease events: the Italian longitudinal study on aging. J Gerontol A Biol Sci Med Sci (2005) 0.84
Patients with CHF and depression have greater risk of mortality and morbidity than patients without depression. J Am Coll Cardiol (2002) 0.82
Does stroke cause depression? J Neuropsychiatry Clin Neurosci (1998) 0.80
Does treating post-myocardial infarction depression reduce medical mortality? Arch Gen Psychiatry (2005) 0.80